Literature DB >> 8280643

Plumboporphyria (ALAD deficiency) in a lead worker: a scenario for potential diagnostic confusion.

J Dyer1, D P Garrick, A Inglis, I F Pye.   

Abstract

A lead worker developed bilateral wrist drop. At first this seemed to be a lead neuropathy but all his screening tests for blood and urine toxicity had been within the accepted safety limit during employment. Detailed investigation showed that he had plumboporphyria (ALAD deficiency) which had been symptom free until he was exposed to lead. Details of his porphyrin metabolism are presented.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8280643      PMCID： PMC1061335          DOI： 10.1136/oem.50.12.1119

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN： 0007-1072


  8 in total

1.  delta-aminolevulinic acid dehydratase in low level lead exposure.

Authors:  O Wada; K Takeo; Y Yano; T Ono; M Nagahashi
Journal:  Arch Environ Health       Date:  1976 Jul-Aug

2.  Determination of lead in blood using electrothermal atomisation atomic absorption spectrometry with a L'vov platform and matrix modifier.

Authors:  D T Miller; D C Paschal; E W Gunter; P E Stroud; J D'Angelo
Journal:  Analyst       Date:  1987-12       Impact factor: 4.616

3.  Studies in lead poisoning. II. Correlation between the ratio of activated to inactivated delta-aminolevulinic acid dehydratase of whole blood and the blood lead level.

Authors:  J L Granick; S Sassa; S Granick; R D Levere; A Kappas
Journal:  Biochem Med       Date:  1973-08

4.  Lead poisoning in inherited delta-aminolevulinic acid dehydratase deficiency.

Authors:  M Doss; F Laubenthal; M Stoeppler
Journal:  Int Arch Occup Environ Health       Date:  1984       Impact factor: 3.015

5.  delta-Aminolaevulinic acid dehydratase as an index of the presence and severity of lead poisoning in acute and chronic lead exposure.

Authors:  Y Lolin; P O'Gorman
Journal:  Ann Clin Biochem       Date:  1986-09       Impact factor: 2.057

6.  In inherited porphyrias, lead intoxication is a toxogenetic disorder.

Authors:  A M Batlle; H Fukuda; V E Parera; E Wider; A M Stella
Journal:  Int J Biochem       Date:  1987

7.  Modified erythrocyte uroporphyrinogen I synthase assay, and its clinical interpretation.

Authors:  M W Piepkorn; P Hamernyik; R F Labbé
Journal:  Clin Chem       Date:  1978-10       Impact factor: 8.327

8.  New type of hepatic porphyria with porphobilinogen synthase defect and intermittent acute clinical manifestation.

Authors:  M Doss; R von Tiepermann; J Schneider; H Schmid
Journal:  Klin Wochenschr       Date:  1979-10-15
  8 in total
  3 in total

1.  Peripheral neuropathy in chronic occupational inorganic lead exposure: a clinical and electrophysiological study.

Authors:  O Rubens; I Logina; I Kravale; M Eglîte; M Donaghy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-08       Impact factor: 10.154

Review 2.  Environmental chemical exposures and disturbances of heme synthesis.

Authors:  W E Daniell; H L Stockbridge; R F Labbe; J S Woods; K E Anderson; D M Bissell; J R Bloomer; R D Ellefson; M R Moore; C A Pierach; W E Schreiber; A Tefferi; G M Franklin
Journal:  Environ Health Perspect       Date:  1997-02       Impact factor: 9.031

3.  Porphyria: What Is It and Who Should Be Evaluated?

Authors:  Yonatan Edel; Rivka Mamet
Journal:  Rambam Maimonides Med J       Date:  2018-04-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.